Patents
Patents for C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
01/2010
01/14/2010US20100009959 Pentacyclic Indole Derivatives as Antiviral Agents
01/13/2010CN101627020A HCV inhibiting macrocyclic phenylcarbamates
01/13/2010CN100579957C Novel arylamidine derivative or salt thereof
01/07/2010US20100003216 HCV NS-3 Serine Protease Inhibitors
01/06/2010EP2139876A1 Cathepsin cysteine protease inhibitors
12/2009
12/17/2009WO2009152051A1 Synthesis of a macrocyclic hcv protease inhibitor
12/17/2009US20090312540 Spatially-defined macrocycles incorporating peptide bond surrogates
12/15/2009US7632943 Method for making 3,3,7,7-tetrakis(difluoramino)octahydro-1,5-dinitro-1,5-diazocine (HNFX)
12/09/2009CN100567271C Improved purification of 4,4'(5')-di-t-butylcyclohexano-18-crown-6
12/03/2009US20090297472 Hepatitis C Virus Inhibitors
11/2009
11/26/2009WO2009142842A2 Novel macrocyclic inhibitors of hepatitis c virus replication
11/26/2009CA2720729A1 Novel macrocyclic inhibitors of hepatitis c virus replication
11/19/2009US20090286843 Macrocyclic compounds as inhibitors of viral replication
11/19/2009US20090286770 Use of Staurosporine Derivatives for the Treatment of Multiple Myeloma
11/17/2009US7618957 1-N-(Benzyloxycarbonyl)-1H,1H,2H,2H,4H,4H,5H,5H-3-aza-perfluorotridecylamine; used in NMR and x-ray diagnosis, radiodiagnosis, and radiotherapy, as well as in MRT lymphography and in blood-pool imaging
11/12/2009US20090281141 Macrocyclic inhibitors of hepatitis c virus
11/12/2009US20090281140 Macrocyclic inhibitors of hepatitis c virus
11/12/2009US20090281139 Macrocyclic factor viia inhibitors useful as anticoagulants
11/12/2009US20090281067 Nitroxyl progenitor compounds and methods of use
11/11/2009EP1713823B1 Hcv ns-3 serine protease inhibitors
11/03/2009US7612055 Macrocyclic lactams and pharmaceutical use thereof
11/03/2009US7612036 Such as methyl (2S,5S,8R/S)-8-acetamido-2-allyl-9-[6-allyl-9-tert-butoxycarbonyl-9H-carbazol-3-yl]-3,6-diaza-5-{3-[(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-guanidino]propyl}-4,7-dioxononanoate; for treatment of bacterial infections, such as those caused by vancomycin resistant microorganisms
11/03/2009US7611888 Rotaxane compound, rotaxane-bonded solid substrate, and biochip using the same
10/2009
10/29/2009US20090269305 Novel macrocyclic inhibitors of hepatitis c virus replication
10/28/2009EP2111396A1 Hcv inhibiting macrocyclic phenylcarbamates
10/27/2009US7608590 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV)
10/13/2009US7601709 Macrocyclic hepatitis C serine protease inhibitors
10/07/2009CN100546982C Material of field effect tube of cyclo triphenylamine organic molecules
10/06/2009CA2616580C Macrocyclic inhibitors of hepatitis c virus
10/01/2009US20090247512 Macrocylic inhibitors of hepatitis c virus
09/2009
09/24/2009US20090240051 New process for the production of oxabispidines
09/22/2009US7592419 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease
09/10/2009US20090227650 Novel crystalline forms of Lestaurtinib
09/01/2009US7582280 Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications
08/2009
08/13/2009US20090203760 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS
08/13/2009US20090203631 Peptide deformylase inhibitors as novel antibiotics
08/13/2009US20090202521 Bifunctional Polyazamacrocyclic Chelating Agents
07/2009
07/23/2009WO2008096001A8 Hcv inhibiting macrocyclic phenylcarbamates
07/23/2009US20090186869 Antiviral compounds
07/22/2009CN101490018A Macrocyclic compounds useful as BACE inhibitors
07/21/2009US7563889 3,3,7,7,-tetrakis(difluoramino)octahydro-1,5-diazocinium salts and method for making the same
07/15/2009EP1866291B1 Antibacterial amide macrocycles vi
07/15/2009CN101484431A Macrocyclic lactams
06/2009
06/18/2009US20090156800 Process for making macrocyclic oximyl hepatitis c protease inhibitors
06/11/2009US20090149491 Carbocyclic oxime hepatitis c virus serine protease inhibitors
06/10/2009EP2066326A2 Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors
06/04/2009WO2009070164A1 Vigor enhancement via administration of pyrimidine derivatives
06/04/2009CA2670341A1 Vigor enhancement via administration of pyrimidine derivatives
05/2009
05/26/2009US7538114 Glycine transporter-1 inhibitors
05/26/2009US7538085 Macrocyclic peptide antibiotics; drug resistant, drug sensitive bacterial infections
05/12/2009US7531543 Phenylpiperazine cycloalkanol derivatives and methods of their use
04/2009
04/29/2009EP2051968A2 Luminescent macrocyclic lanthanide complexes
04/23/2009US20090105471 Macrocyclic compounds as inhibitors of viral replication
04/15/2009EP2046761A2 Macrocyclic compounds useful as bace inhibitors
04/15/2009EP2046760A1 Macrocyclic lactams
04/14/2009US7517882 Protein kinase inhibitors
04/09/2009US20090093533 Compounds and methods for inhibiting hepatitis c viral replication
04/09/2009US20090092550 Porphyrin linked metronidazole against gum disease: porphyromonas gingivalis
03/2009
03/26/2009WO2009037642A1 Heterocyclic scaffolds useful for preparation of combinatorial libraries, libraries and methods of preparation thereof
03/24/2009US7507726 Antibiotic; bactericides
03/19/2009US20090074833 Bridged polycyclic compound based compositions for controlling bone resorption
03/18/2009CN101389613A Macrocyclic factor viia inhibitors useful as anticoagulants
03/05/2009US20090062311 Macrocylic inhibitors of hepatitis c virus
02/2009
02/26/2009US20090054460 Piperazine derivatives and methods of use
02/10/2009US7488819 Coordination sites of four nitrogen-containing groups of of imino, amido and amino groups, and has the nitrogen atoms of the four nitrogen-containing groups as coordinating atoms in one plane; metal complex assembly; acceptor and a donor interacting with each other; nanostructure; semiconductors
02/05/2009US20090036675 New process for production of oxabispidines
02/05/2009US20090035271 Tetrazolyl macrocyclic hepatitis c serine protease inhibitors
02/03/2009US7485630 e.g. 2-{[(3'-Amino-1'-aza-2'-oxobicyclo[6.3.0]-undecyl)-11'-carbonyl]amino}-1,5-pentanedioic acid; tripeptide Gly-Pro-Glu (GPE) mimetic; enzymatic degradation, ischemic injury, hypoxic injury, reperfusion injury, and asphyxia
01/2009
01/22/2009US20090023928 Phthalamide-lanthanide complexes for use as luminescent markers
01/21/2009CN101351455A Macrocyclic compounds useful as BACE inhibitors
12/2008
12/23/2008US7468435 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
12/17/2008CN100443476C Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
12/11/2008US20080306040 Antibacterial amide macrocycles VII
12/04/2008US20080300231 Antibacterial amide macrocycles VI
12/04/2008US20080299675 Luminescent Lanthanide Binding Chelates
11/2008
11/27/2008US20080293932 Phthalocyanine recording layer of optical recording media
11/06/2008WO2008063721A3 Luminescent macrocyclic lanthanide complexes
10/2008
10/28/2008US7442558 Phthalamide-lanthanide complexes for use as luminescent markers
10/23/2008US20080260676 Enhanced solubility in common solvents; ion sensor; removal odors; water and air pollution control
10/21/2008US7439355 Process for the production of oxabispidines
10/08/2008CN101282978A Macrocylic inhibitors of hepatitis c virus
10/02/2008WO2008117796A1 Novel mutilin derivatives
10/02/2008WO2008116302A1 Cathepsin cysteine protease inhibitors
10/01/2008EP1654239A4 Peptide deformylase inhibitors
09/2008
09/24/2008EP1971582A1 Macrocyclic factor viia inhibitors useful as anticoagulants
09/24/2008CN101273027A Macrocyclic inhibitors of hepatitis C virus
09/23/2008US7427613 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
09/17/2008EP1968954A1 Macrocyclic compounds useful as bace inhibitors
09/04/2008US20080214526 Macrocyclic Compounds and Compositions Useful as Bace Inhibitors
09/02/2008CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors
08/2008
08/14/2008WO2008096001A1 Hcv inhibiting macrocyclic phenylcarbamates
08/14/2008CA2677015A1 Hcv inhibiting macrocyclic phenylcarbamates
08/13/2008CN100410296C Silica gel bonded with cucurbiturils
08/05/2008CA2466934C Improved purification of 4, 4'(5')-di-t-butylcyclohexano-18-crown-6
07/2008
07/30/2008CN101233117A Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
07/29/2008US7404912 Salicylamide-lanthanide complexes for use as luminescent markers
07/24/2008US20080177063 CRYSTALLINE K-252b, SODIUM SALT, HYDRATE
07/24/2008US20080177062 crystal structured (9S-(9 alpha ,10 beta ,12 alpha ))-2,3,9,10,11,12-hexahydro-10-hydroxy-10-(methoxycarbonyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one bis(N,N'-dimethylformamidate); enzyme inhibitors
07/23/2008CN101228169A Macrocyclic inhibitors of hepatitis c virus
07/17/2008US20080171735 SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
1 2 3 4 5 6 7 8 9